Latest Insider Transactions at Fibrogen Inc (FGEN)
This section provides a real-time view of insider transactions for Fibrogen Inc (FGEN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of FIBROGEN INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of FIBROGEN INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 06
2023
|
Enrique A Conterno Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,538
-0.52%
|
$29,222
$19.95 P/Share
|
|
Dec 23
2022
|
Thane Wettig CEO |
SELL
Open market or private sale
|
Direct |
734
-0.82%
|
$11,010
$15.8 P/Share
|
|
Dec 12
2022
|
Juan Graham CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,407
-2.55%
|
$19,698
$14.5 P/Share
|
|
Dec 09
2022
|
Juan Graham CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
781
-1.4%
|
$10,934
$14.9 P/Share
|
|
Dec 08
2022
|
Juan Graham CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,741
-5.18%
|
$86,115
$15.16 P/Share
|
|
Dec 08
2022
|
Thane Wettig CEO |
SELL
Open market or private sale
|
Direct |
382
-0.42%
|
$5,730
$15.79 P/Share
|
|
Dec 08
2022
|
Enrique A Conterno Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,543
-0.85%
|
$38,145
$15.79 P/Share
|
|
Dec 08
2022
|
Christine Chung SVP, CHINA OPERATIONS |
SELL
Open market or private sale
|
Direct |
1,096
-0.46%
|
$16,440
$15.79 P/Share
|
|
Dec 01
2022
|
Mark Eisner EVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,084
-0.76%
|
$16,260
$15.04 P/Share
|
|
Oct 06
2022
|
Enrique A Conterno Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,296
-0.43%
|
$18,144
$14.26 P/Share
|
|
Sep 30
2022
|
Mark Eisner EVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,777
-4.55%
|
$88,101
$13.01 P/Share
|
|
Sep 30
2022
|
Christine Chung SVP, CHINA OPERATIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
4,683
-1.92%
|
$60,879
$13.01 P/Share
|
|
Sep 22
2022
|
Thane Wettig CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
655
-0.72%
|
$7,860
$12.26 P/Share
|
|
Sep 07
2022
|
Juan Graham CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,009
-5.11%
|
$36,108
$12.62 P/Share
|
|
Sep 06
2022
|
Thane Wettig CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
360
-0.39%
|
$4,320
$12.26 P/Share
|
|
Sep 06
2022
|
Enrique A Conterno Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,772
-0.59%
|
$21,264
$12.26 P/Share
|
|
Sep 06
2022
|
Christine Chung SVP, CHINA OPERATIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
518
-0.21%
|
$6,216
$12.26 P/Share
|
|
Sep 01
2022
|
Mark Eisner EVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
756
-0.5%
|
$9,828
$13.09 P/Share
|
|
Jul 06
2022
|
Enrique A Conterno Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,296
-0.43%
|
$15,552
$12.4 P/Share
|
|
Jun 22
2022
|
Thane Wettig CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
655
-0.71%
|
$7,205
$11.42 P/Share
|
|
Jun 16
2022
|
James A Schoeneck |
BUY
Grant, award, or other acquisition
|
Direct |
15,777
+43.52%
|
-
|
|
Jun 16
2022
|
Gerald Lema |
BUY
Grant, award, or other acquisition
|
Direct |
15,777
+43.52%
|
-
|
|
Jun 16
2022
|
Suzanne Blaug |
BUY
Grant, award, or other acquisition
|
Direct |
15,777
+34.6%
|
-
|
|
Jun 16
2022
|
Aoife Brennan |
BUY
Grant, award, or other acquisition
|
Direct |
15,777
+39.28%
|
-
|
|
Jun 16
2022
|
Benjamin Cravatt |
BUY
Grant, award, or other acquisition
|
Direct |
15,777
+39.28%
|
-
|
|
Jun 16
2022
|
Jeffrey L Edwards |
BUY
Grant, award, or other acquisition
|
Direct |
15,777
+31.97%
|
-
|
|
Jun 16
2022
|
Jeffrey William Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,777
+31.97%
|
-
|
|
Jun 16
2022
|
Maykin Ho |
BUY
Grant, award, or other acquisition
|
Direct |
15,777
+33.21%
|
-
|
|
Jun 06
2022
|
Thane Wettig CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
360
-0.4%
|
$3,240
$9.5 P/Share
|
|
Jun 06
2022
|
Enrique A Conterno Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,772
-0.58%
|
$15,948
$9.5 P/Share
|
|
Jun 06
2022
|
Christine Chung SVP, CHINA OPERATIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
1,850
-0.75%
|
$16,650
$9.5 P/Share
|
|
Jun 01
2022
|
Mark Eisner EVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,141
-0.76%
|
$10,269
$9.61 P/Share
|
|
Apr 07
2022
|
Enrique A Conterno Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,311
-0.43%
|
$15,732
$12.73 P/Share
|
|
Mar 31
2022
|
Mark Eisner EVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,442
-4.09%
|
$77,304
$12.02 P/Share
|
|
Mar 31
2022
|
Christine Chung SVP, CHINA OPERATIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
4,682
-1.87%
|
$56,184
$12.02 P/Share
|
|
Mar 22
2022
|
Thane Wettig CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
655
-0.72%
|
$8,515
$13.31 P/Share
|
|
Mar 07
2022
|
Enrique A Conterno Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,081
-2.27%
|
$84,972
$12.69 P/Share
|
|
Mar 07
2022
|
Christine Chung SVP, CHINA OPERATIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
3,905
-1.53%
|
$46,860
$12.69 P/Share
|
|
Mar 07
2022
|
Thane Wettig CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,706
-1.84%
|
$20,472
$12.69 P/Share
|
|
Mar 01
2022
|
Mark Eisner EVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
756
-0.48%
|
$9,828
$13.62 P/Share
|
|
Feb 14
2022
|
Enrique A Conterno Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
179,400
+36.5%
|
-
|
|
Feb 14
2022
|
Christine Chung SVP, CHINA OPERATIONS |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+15.03%
|
-
|
|
Feb 14
2022
|
Mark Eisner EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+27.51%
|
-
|
|
Feb 14
2022
|
Juan Graham CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+27.64%
|
-
|
|
Feb 14
2022
|
Thane Wettig CEO |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+32.68%
|
-
|
|
Jan 06
2022
|
Enrique A Conterno Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,536
-1.14%
|
$19,968
$13.93 P/Share
|
|
Jan 03
2022
|
Christine Chung SVP, CHINA OPERATIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
5,284
-2.46%
|
$73,976
$14.82 P/Share
|
|
Jan 03
2022
|
Mark Eisner EVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,043
-6.7%
|
$98,602
$14.82 P/Share
|
|
Dec 22
2021
|
Thane Wettig CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
517
-1.07%
|
$7,238
$14.97 P/Share
|
|
Dec 06
2021
|
Christine Chung SVP, CHINA OPERATIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
2,668
-1.23%
|
$37,352
$14.19 P/Share
|